Targets and Emerging Therapies for Schizophrenia

Nonfiction, Health & Well Being, Medical, Medical Science, Pharmacology
Cover of the book Targets and Emerging Therapies for Schizophrenia by Jeffrey S. Albert, Wiley
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Jeffrey S. Albert ISBN: 9781118309407
Publisher: Wiley Publication: June 6, 2012
Imprint: Wiley Language: English
Author: Jeffrey S. Albert
ISBN: 9781118309407
Publisher: Wiley
Publication: June 6, 2012
Imprint: Wiley
Language: English

New and emerging directions in pharmaceutical research to better treat schizophrenia

Although the dopamine hypothesis has been the cornerstone of schizophrenia therapeutics, it is clear that dopamine-based approaches do not treat all aspects of the disease. Moreover, many schizophrenia patients fail to respond to current antipsychotics. Integrating chemistry, biology, and pharmacology, this book explores emerging directions in pharmaceutical research for drug targeting and discovery in order to find more effective treatments for schizophrenia, one of the most serious and widespread psychiatric diseases.

Targets and Emerging Therapies for Schizophrenia presents the basics of schizophrenia, drug targets for the disease, and potential new drugs and therapeutics. It begins with a discussion of prevalence and etiology. Then, it describes therapies such as dopamine agonists and phosphodiesterase (PDE) inhibitors as well as growing research aimed at addressing untreated symptoms. Next, the authors discuss receptor modulators, inhibitors, and targeting strategies for drug discovery. Both the neurobiological and chemical aspects of all major pharmacological targets are examined.

With contributions from an international team of pioneering pharmaceutical researchers, this book compiles the current knowledge in the field, setting the stage for new breakthroughs in the treatment of schizophrenia. Targets and Emerging Therapies for Schizophrenia:

  • Provides a comprehensive resource for neuro-drug discovery and the development of molecular targets for schizophrenia treatment
  • Draws from chemistry, biology, and pharmacology for more effective drug targeting and discovery
  • Explores a wide range of receptors and molecular targets, including dopamine, PDEs, and neuropeptides

With Targets and Emerging Therapies for Schizophrenia as their guide, drug discovery and development scientists have the information they need to advance their own research so that new, more effective treatments for schizophrenia will soon be a reality.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

New and emerging directions in pharmaceutical research to better treat schizophrenia

Although the dopamine hypothesis has been the cornerstone of schizophrenia therapeutics, it is clear that dopamine-based approaches do not treat all aspects of the disease. Moreover, many schizophrenia patients fail to respond to current antipsychotics. Integrating chemistry, biology, and pharmacology, this book explores emerging directions in pharmaceutical research for drug targeting and discovery in order to find more effective treatments for schizophrenia, one of the most serious and widespread psychiatric diseases.

Targets and Emerging Therapies for Schizophrenia presents the basics of schizophrenia, drug targets for the disease, and potential new drugs and therapeutics. It begins with a discussion of prevalence and etiology. Then, it describes therapies such as dopamine agonists and phosphodiesterase (PDE) inhibitors as well as growing research aimed at addressing untreated symptoms. Next, the authors discuss receptor modulators, inhibitors, and targeting strategies for drug discovery. Both the neurobiological and chemical aspects of all major pharmacological targets are examined.

With contributions from an international team of pioneering pharmaceutical researchers, this book compiles the current knowledge in the field, setting the stage for new breakthroughs in the treatment of schizophrenia. Targets and Emerging Therapies for Schizophrenia:

With Targets and Emerging Therapies for Schizophrenia as their guide, drug discovery and development scientists have the information they need to advance their own research so that new, more effective treatments for schizophrenia will soon be a reality.

More books from Wiley

Cover of the book Improvised Lives by Jeffrey S. Albert
Cover of the book The Future of Live by Jeffrey S. Albert
Cover of the book Nikon D5500 For Dummies by Jeffrey S. Albert
Cover of the book The Handbook of Interior Design by Jeffrey S. Albert
Cover of the book The Quantified Self by Jeffrey S. Albert
Cover of the book Islamic Money and Banking by Jeffrey S. Albert
Cover of the book Grundlagen der Elektronenspektroskopie by Jeffrey S. Albert
Cover of the book Mastering Global Corporate Governance by Jeffrey S. Albert
Cover of the book The Science of ADHD by Jeffrey S. Albert
Cover of the book Low Molecular Weight Organic Semiconductors by Jeffrey S. Albert
Cover of the book Running for Freedom by Jeffrey S. Albert
Cover of the book An Introduction to Repo Markets by Jeffrey S. Albert
Cover of the book Visible Light Communications by Jeffrey S. Albert
Cover of the book 5G Explained by Jeffrey S. Albert
Cover of the book Fundamentals of Applied Pathophysiology by Jeffrey S. Albert
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy